Submissions for variant NM_001242896.3(DEPDC5):c.4214G>A (p.Trp1405Ter)

Total submissions: 2

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute	RCV004595401	SCV005086682	pathogenic	Epilepsy, familial focal, with variable foci 1	2024-09-19	criteria provided, single submitter	clinical testing	Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with familial focal epilepsy with variable foci 1 (MIM#604364). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance. Unaffected individuals with pathogenic familial variants are commonly reported, with penetrance estimated to be between 66% and 70% (PMIDs: 30767899, 32848577). (I) 0115 - Variants in this gene are known to have variable expressivity. Disease presentation in affected individuals is known to vary considerably even within the same family, from mild febrile seizures to severe focal epilepsy with cortical malformations (PMIDs: 27066554, 32848577). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. Many NMD-predicted variants have previously been reported as pathogenic in individuals with familial focal epilepsy with variable foci 1 (DECIPHER). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1102 - Strong phenotype match for this individual. (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign
Labcorp Genetics (formerly Invitae), Labcorp	RCV005102052	SCV005842313	pathogenic	Familial focal epilepsy with variable foci	2024-10-31	criteria provided, single submitter	clinical testing	This sequence change creates a premature translational stop signal (p.Trp1405*) in the DEPDC5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DEPDC5 are known to be pathogenic (PMID: 23542697, 23542701). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DEPDC5-related conditions. ClinVar contains an entry for this variant (Variation ID: 3255218). For these reasons, this variant has been classified as Pathogenic.